Oral Antibiotics for Oxacillin-Sensitive Staphylococcus epidermidis
For oxacillin-sensitive Staphylococcus epidermidis, use dicloxacillin 500 mg four times daily or cephalexin 500 mg four times daily as first-line oral therapy. These are the preferred oral agents for methicillin-susceptible staphylococcal infections 1, 2.
Primary Oral Options
The IDSA guidelines clearly designate oral agents for oxacillin-susceptible (methicillin-susceptible) staphylococci 1, 2:
First-Line Choices:
- Dicloxacillin 500 mg four times daily – This is explicitly listed as the "oral agent of choice for methicillin-susceptible strains" in adults 1, 2
- Cephalexin 500 mg four times daily – Recommended for penicillin-allergic patients (except those with immediate hypersensitivity reactions) 1, 2
Alternative Oral Options:
If first-line agents cannot be used due to allergies or intolerances 3:
- Clindamycin 300-450 mg four times daily – Bacteriostatic with good staphylococcal coverage 1, 2
- Amoxicillin-clavulanate 875/125 mg twice daily 1, 2
- Cefadroxil 500 mg twice daily 3
Additional Options (with caveats):
- Doxycycline or minocycline 100 mg twice daily – Bacteriostatic with limited recent clinical experience; not recommended for children <8 years 1, 2
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily – Bactericidal but efficacy poorly documented for staphylococcal infections 1, 2
Important Clinical Considerations
Oxacillin sensitivity means methicillin sensitivity, so you can confidently use beta-lactam antibiotics. The organism is susceptible to penicillinase-resistant penicillins and first-generation cephalosporins 4, 5.
Key Pitfalls to Avoid:
Don't use penicillin G or amoxicillin alone – Even oxacillin-sensitive S. epidermidis typically produces penicillinase, making these ineffective 4
Fluoroquinolones are NOT recommended – While ciprofloxacin and levofloxacin appear in guidelines, they are explicitly "not recommended for use in patients with staphylococcal" infections as monotherapy 6
Consider the infection type – For prosthetic joint infections or other device-related infections with S. epidermidis, rifampin combination therapy may be needed after initial treatment, though rifampin should never be used alone 3
Duration and Monitoring:
Treatment duration depends on the infection site and severity. For skin and soft tissue infections, typically 7-10 days is adequate 1, 2. For more serious infections like osteomyelitis or prosthetic joint infections, prolonged therapy (4-6 weeks or longer) may be required 3.
Monitor for treatment response clinically – improvement in signs of infection, resolution of fever, and decreasing inflammatory markers indicate adequate therapy.